Skip to content
10-K

Annual Report

EMMAUS LIFE SCIENCES, INC.

0001564590-18-008230

← back to feed
Filed
Apr 16, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Mar 20, 2018 34.91M sh
Capex FY 2017 · Dec 31, 2016 $10.37K
Cash And Equivalents FY 2017 · Dec 31, 2016 $1.32M
Stockholders Equity FY 2017 · Dec 31, 2016 −$17.56M
Current Liabilities restated FY 2017 · Dec 31, 2016 $18.92M
Total Liabilities FY 2017 · Dec 31, 2016 $30.55M
Current Assets FY 2017 · Dec 31, 2016 $12.72M
Total Assets FY 2017 · Dec 31, 2016 $12.99M
Eps Basic FY 2017 · Dec 31, 2016 −$0.70
Sga Expense FY 2017 · Dec 31, 2016 $9.34M
Rd Expense FY 2017 · Dec 31, 2016 $1.99M
Net Income FY 2017 · Dec 31, 2016 −$21.18M
Operating Income FY 2017 · Dec 31, 2016 −$11.53M
Gross Profit FY 2017 · Dec 31, 2016 $240.34K
Cost Of Revenue FY 2017 · Dec 31, 2016 $221.25K